Also categorized in Specialties - Oncology:
Routine HPV Testing may be Warranted for Sinonasal Cancers
x hide permanently

Study Provides Clarity on Use of Anticoagulants in Gastrointestinal Cancers

Medical Xpress

Photo: CC0 Public Domain

medicalxpress.com

A study by Mayo Clinic researchers provides some clarity in the use of direct oral anticoagulants (DOAC), such as apixaban and rivaroxaban, to treat acute venous thromboembolism (VTE) in patients with gastrointestinal cancers. The findings were published Wednesday, June 2, in Mayo Clinic Proceedings.

Among the study's findings:

  • Rivaroxaban showed no higher risk of bleeding in luminal gastrointestinal cancer and should not be considered contraindicated in this group of patients.
  • Apixaban showed a higher risk of bleeding in patients with luminal gastrointestinal cancer, and it should be used with great caution to treat ...